SAGA Diagnostics enters into an assay development agreement with AstraZeneca
- Tuesday, November 2, 2021, 6:07
- Finance
- Add a comment
LUND, Sweden, Nov. 2, 2021 /PRNewswire/ — SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, has entered into an assay development agreement with the global, science-led…
About the Author
adminasapcorp has written 39063 stories on this site.